164 related articles for article (PubMed ID: 21619545)
1. The polyamine pathway as a potential target for vascular diseases: focus on restenosis.
Forte A; Hellstrand P; Nilsson BO; Grossi M; Rossi F; Cipollaro M
Curr Vasc Pharmacol; 2011 Nov; 9(6):706-14. PubMed ID: 21619545
[TBL] [Abstract][Full Text] [Related]
2. Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research.
Forte A; Rinaldi B; Berrino L; Rossi F; Galderisi U; Cipollaro M
Clin Sci (Lond); 2014 Dec; 127(11):615-34. PubMed ID: 25072327
[TBL] [Abstract][Full Text] [Related]
3. Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits.
Hytönen JP; Taavitsainen J; Laitinen JTT; Partanen A; Alitalo K; Leppänen O; Ylä-Herttuala S
J Mol Cell Cardiol; 2018 Aug; 121():145-154. PubMed ID: 30003882
[TBL] [Abstract][Full Text] [Related]
4. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
5. [Gene therapy of restenosis and atherosclerosis: hopes and facts].
Mazighi M; Tchétché D; Hyafil F; Feldman LJ
Pathol Biol (Paris); 2004 May; 52(4):212-7. PubMed ID: 15145134
[TBL] [Abstract][Full Text] [Related]
6. [Restenosis after coronary angioplasty: pathomechanism and potential targets for therapeutic intervention. Focus on inflammation].
Koziński M; Sukiennik A; Rychter M; Kubica J; Sinkiewicz W
Postepy Hig Med Dosw (Online); 2007; 61():58-73. PubMed ID: 17369774
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Polyamine Uptake Potentiates the Anti-Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells.
Grossi M; Phanstiel O; Rippe C; Swärd K; Alajbegovic A; Albinsson S; Forte A; Persson L; Hellstrand P; Nilsson BO
J Cell Physiol; 2016 Jun; 231(6):1334-42. PubMed ID: 26529275
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
[TBL] [Abstract][Full Text] [Related]
9. Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury.
Forte A; Grossi M; Turczynska KM; Svedberg K; Rinaldi B; Donniacuo M; Holm A; Baldetorp B; Vicchio M; De Feo M; Santè P; Galderisi U; Berrino L; Rossi F; Hellstrand P; Nilsson BO; Cipollaro M
Int J Cardiol; 2013 Oct; 168(4):3370-80. PubMed ID: 23680596
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.
Kuchulakanti P; Waksman R
Drugs; 2004; 64(21):2379-88. PubMed ID: 15481997
[TBL] [Abstract][Full Text] [Related]
11. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
Nishihira K; Shibata Y; Ishikawa T; Nomura K; Nakama T; Mine D; Inoue Y; Ashikaga K; Kuriyama N; Matsuyama A; Imamura T; Asada Y; Kitamura K
Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
[TBL] [Abstract][Full Text] [Related]
14. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
15. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
[TBL] [Abstract][Full Text] [Related]
16. Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm.
Forte A; Della Corte A; De Feo M; Cerasuolo F; Cipollaro M
Cardiovasc Res; 2010 Dec; 88(3):395-405. PubMed ID: 20621923
[TBL] [Abstract][Full Text] [Related]
17. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials.
Byrne RA; Cassese S; Windisch T; King LA; Joner M; Tada T; Mehilli J; Pache J; Kastrati A
EuroIntervention; 2013 Nov; 9(7):797-802. PubMed ID: 23687095
[TBL] [Abstract][Full Text] [Related]
18. In-stent restenosis.
Kim MS; Dean LS
Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
[TBL] [Abstract][Full Text] [Related]
19. Management of drug-eluting stent restenosis.
Ishikawa K; Aoyama Y; Hirayama H
J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
